B16.0-2/B16.9
GENERAL MEASURES
Bed-rest until acute phase is over.
Avoid alcohol during the illness and for ≥ 6 months after clinical recovery.
Screen sexual contacts of patients with acute hepatitis B.
If they are non-immune (negative for hepatitis B antibodies) then they should receive hepatitis B active immunisation.
MEDICINE TREATMENT
For nausea and vomiting: (R11)
- Metoclopramide, IV/oral, 10 mg 8 hourly as required.
Hepatitis B virus: prophylaxis following exposure e.g. needle stick injury
S61.0 + (W46.22+Z20.5+Z29.8)
Persons at risk can be protected by passive immunisation with hyper immune serum globulin prepared from blood containing anti-HBs.
It is essential that all categories of healthcare workers (HCW) who are at risk of exposure, including cleaning staff, be fully vaccinated against hepatitis B.
All exposure incidents must be adequately documented for possible subsequent compensation.
Recommended post-exposure management for HCW exposed to infectious material from patients with infectious hepatitis B (either surface antigen or e antigen positive).
Vaccination status and antibody response status of HCW |
Source patient status & treatment |
||
---|---|---|---|
HBsAg positive | HBsAg negative | HBsAg unknown | |
Unvaccinated OR vaccination incomplete |
units* Hep B vaccine (3 doses at monthly intervals) |
vaccination (month 0, 1 and 6) |
units* (3 doses at monthly intervals) |
Vaccinated AND HBsAb > 10 units/mL** |
No treatment | No treatment | No treatment |
Vaccinated AND HBsAb < 10 units/mL |
500 units * Repeat Hep B vaccine (3 doses at monthly intervals) |
vaccination (month 0, 1 and 6) |
500 units* (3 doses at monthly intervals) |
*HBIG and first dose of vaccine to be given simultaneously, but at different sites.
**If the delay in obtaining HBsAb results is more than 24 hours initiate treatment as for vaccinated AND HBsAb < 10 units/mL.